Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| type I pneumocyte | 12 studies | 31% ± 12% | |
| epithelial cell | 11 studies | 34% ± 15% | |
| ciliated cell | 7 studies | 28% ± 12% | |
| type II pneumocyte | 6 studies | 27% ± 9% | |
| endothelial cell | 6 studies | 22% ± 5% | |
| club cell | 5 studies | 28% ± 15% | |
| hepatocyte | 4 studies | 34% ± 18% | |
| secretory cell | 4 studies | 25% ± 7% | |
| goblet cell | 4 studies | 26% ± 10% | |
| kidney loop of Henle epithelial cell | 3 studies | 22% ± 5% | |
| cholangiocyte | 3 studies | 52% ± 15% | |
| luminal cell of prostate epithelium | 3 studies | 22% ± 5% | |
| pancreatic ductal cell | 3 studies | 54% ± 26% | |
| intestinal crypt stem cell | 3 studies | 17% ± 2% | |
| basal cell | 3 studies | 23% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 1078.50 | 328 / 328 | 88% | 9.75 | 157 / 178 |
| thymus | 100% | 1734.78 | 652 / 653 | 85% | 20.88 | 514 / 605 |
| liver | 100% | 653.34 | 226 / 226 | 81% | 11.75 | 330 / 406 |
| lung | 99% | 1179.90 | 575 / 578 | 82% | 13.07 | 942 / 1155 |
| stomach | 76% | 938.56 | 274 / 359 | 97% | 17.19 | 277 / 286 |
| prostate | 74% | 193.08 | 182 / 245 | 88% | 9.94 | 441 / 502 |
| kidney | 98% | 483.45 | 87 / 89 | 58% | 6.14 | 519 / 901 |
| breast | 60% | 242.73 | 277 / 459 | 90% | 12.77 | 1010 / 1118 |
| intestine | 53% | 427.78 | 508 / 966 | 97% | 13.61 | 512 / 527 |
| esophagus | 44% | 391.56 | 635 / 1445 | 79% | 14.84 | 145 / 183 |
| bladder | 43% | 329.90 | 9 / 21 | 72% | 7.71 | 365 / 504 |
| ovary | 18% | 41.93 | 32 / 180 | 93% | 8.55 | 398 / 430 |
| uterus | 25% | 72.79 | 42 / 170 | 62% | 5.47 | 285 / 459 |
| skin | 73% | 716.74 | 1317 / 1809 | 2% | 0.10 | 9 / 472 |
| brain | 61% | 130.74 | 1606 / 2642 | 2% | 0.08 | 14 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 44% | 3.26 | 20 / 45 |
| spleen | 16% | 35.09 | 39 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 16% | 46.23 | 147 / 929 | 0% | 0 | 0 / 0 |
| adipose | 14% | 27.08 | 163 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 8% | 14.21 | 105 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 5% | 9.10 | 14 / 258 | 0% | 0 | 0 / 230 |
| heart | 3% | 3.95 | 23 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.14 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0046326 | Biological process | positive regulation of glucose import |
| GO_0010629 | Biological process | negative regulation of gene expression |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0010592 | Biological process | positive regulation of lamellipodium assembly |
| GO_0031116 | Biological process | positive regulation of microtubule polymerization |
| GO_0045216 | Biological process | cell-cell junction organization |
| GO_0065003 | Biological process | protein-containing complex assembly |
| GO_0001933 | Biological process | negative regulation of protein phosphorylation |
| GO_0070830 | Biological process | bicellular tight junction assembly |
| GO_1902463 | Biological process | protein localization to cell leading edge |
| GO_0035633 | Biological process | maintenance of blood-brain barrier |
| GO_1905605 | Biological process | positive regulation of blood-brain barrier permeability |
| GO_0010827 | Biological process | regulation of glucose transmembrane transport |
| GO_0090303 | Biological process | positive regulation of wound healing |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0070160 | Cellular component | tight junction |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031410 | Cellular component | cytoplasmic vesicle |
| GO_0030139 | Cellular component | endocytic vesicle |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0031252 | Cellular component | cell leading edge |
| GO_0005911 | Cellular component | cell-cell junction |
| GO_0005923 | Cellular component | bicellular tight junction |
| GO_0030054 | Cellular component | cell junction |
| GO_0016327 | Cellular component | apicolateral plasma membrane |
| GO_0005765 | Cellular component | lysosomal membrane |
| GO_0019904 | Molecular function | protein domain specific binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | OCLN |
| Protein name | Occludin |
| Synonyms | |
| Description | FUNCTION: May play a role in the formation and regulation of the tight junction (TJ) paracellular permeability barrier. It is able to induce adhesion when expressed in cells lacking tight junctions. .; FUNCTION: (Microbial infection) Acts as a coreceptor for hepatitis C virus (HCV) in hepatocytes. . FUNCTION: May play a role in the formation and regulation of the tight junction (TJ) paracellular permeability barrier. . |
| Accessions | ENST00000355237.6 [Q16625-1] A0A0G2JPF2 ENST00000681588.1 ENST00000620655.1 ENST00000681041.1 [Q16625-1] ENST00000615870.4 ENST00000617110.4 A0A0G2JMZ8 A0A7P0TB95 ENST00000680027.1 [Q16625-1] ENST00000681586.1 [Q16625-1] ENST00000680784.1 [Q16625-2] ENST00000613193.4 Q16625 ENST00000680496.1 [Q16625-2] ENST00000538151.2 [Q16625-4] ENST00000681895.1 ENST00000680098.1 A0A7P0T9T6 ENST00000396442.7 [Q16625-1] |